US 12,090,183
Application 17/822,677 · Granted Sep 17, 2024
Methods of treating solid or lymphatic tumors by combination therapy
Estimated expiration
March 9, 2037
10y 111d remaining
Earliest effective filing
Mar 9, 2017
+ 20 years
Mar 9, 2037
PTA +0d
Mar 9, 2037
TD cap (US 11,497,781)
Mar 9, 2037
Final
Mar 9, 2037
- Earliest effective filing
- Mar 9, 2017
- + 20 years
- Mar 9, 2037
- PTA +0d
- Mar 9, 2037
- TD cap (US 11,497,781)
- Mar 9, 2037
- Final
- Mar 9, 2037
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- August 26, 2022
- Earliest effective filing
- March 9, 2017
- Issue date
- September 17, 2024
- PTA
- 0 days
- Base expiry (before PTA)
- March 9, 2037
March 9, 2017 + 20 years = March 9, 2037
- Continuation of application 16/083,709, filed Sep 10, 2018, issued as US 11,497,781
- National stage entry of application PCTUS2017021694, filed Mar 9, 2017
- National stage entry of application PCTUS2017021694, filed Mar 9, 2017
- PRO62/306,470 — Provisional — not used for base term
- PRO62/306,470 — Provisional — not used for base term
- PRO62/306,470 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to March 9, 2037 (earliest expiring referenced patent: US 11,497,781)
US 11,497,781· Application 16/083,709Capping patent
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus cg0070 and an immune checkpoint inhibitor
- Filing date
- Sep 10, 2018
- Earliest effective filing
- Mar 9, 2017
- Issue date
- Nov 15, 2022
- PTA
- 0 days
- Calculated expiration
- Mar 9, 2037
National stage entry of PCTUS2017021694, filed Mar 9, 2017
Mar 9, 2017 + 20y = Mar 9, 2037
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 17/822,677 · US 12,090,183
PatentReply compiles the prosecution history behind US 12,090,183: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12090183Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.